VAERS Reports 0007B21A

VAERS 1417648

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0007B21A

mild

Staat: TN
Alter: 61,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 27.04.2021
Beginn: 27.05.2021
Tage bis Beginn: 30,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Dizziness Heart rate decreased Pancreatitis

Symptomtext

On June 1, I was hospitalized for pancreatitis although I had none of the preexisting conditions for it such as a history of drinking alcohol or anything else that the hospital could find. Next on June 16, I began feeling lightheaded. I went to an internal medicine doctor who referred me to a specialist. After some testing, Doctor informed me that my heart was beating lower than the normal range. I just had a heart stress test done a few years earlier and my heart was more than fine. It is hard for me to understand how my heart health could have such a dramatic reversal so quickly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: TYPE 2 DIABETES
Andere Medikamente: ZIGDUO XR, LISINOPRIL, GARLIC, FISH OIL,GINGER
Allergien: IODINE, ASPIRIN, LATEX, PENICILLIN
Vorherige Impfungen: -

VAERS 1605191

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0007B21A

gering

Staat: TX
Alter: 74,0
Geschlecht: F
Eingang: 22.08.2021
Impfdatum: -
Beginn: 08.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Patient received the 2nd dose 6 days after the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the 2nd dose 6 days after the 1st dose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0007B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the 2nd dose 6 days after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the 2nd dose 6 days after the 1st dose) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment was unknown. Action taken with mRNA-1273 in response to the event was not applicable. List of concomitant medication were not given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -